Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1

Potential estrogen receptor autocrine signaling loop in breast cancer cells

Rajib Rajhans, Hareesh B. Nair, Sujit S. Nair, Valerie Cortez, Kijima Ikuko, Nameer B. Kirma, Dujin Zhou, Alan E. Holden, Darrell W Brann, Shiuan Chen, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

In situ estrogen synthesis is implicated in tumor cell proliferation through autocrine or paracrine mechanisms especially in postmenopausal women. Several recent studies demonstrated activity of aromatase, an enzyme that plays a critical role in estrogen synthesis in breast tumors. Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1/MNAR) is an estrogen receptor (ER) coregulator, and its expression is deregulated in breast tumors. In this study, we examined whether PELP1 promotes tumor growth by promoting local estrogen synthesis using breast cancer cells (MCF7) that stably overexpress PELP1. Immunohistochemistry revealed increased aromatase expression in MCF7-PELP1-induced xenograft tumors. Real-time PCR analysis showed enhanced activation of the aromatase promoter in MCF7-PELP1 clones compared with MCF7 cells. Using a tritiated-water release assay, we demonstrated that MCF7-PELP1 clones exhibit increased aromatase activity compared with control MCF-7 cells. PELP1 deregulation uniquely up-regulated aromatase expression via activation of aromatase promoter I.3/II, and growth factor signaling enhanced PELP1 activation of aromatase. PELP1-mediated induction of aromatase requires functional Src and phosphatidylinositol-3-kinase pathways. Mechanistic studies revealed that PELP1 interactions with ER-related receptor-α and proline-rich nuclear receptor coregulatory protein 2 lead to activation of aromatase. Immunohistochemistry analysis of breast tumor array showed increased expression of aromatase in ductal carcinoma in situ and node-positive tumors compared with no or weak expression in normal breast tissue. Fifty-four percent (n = 79) of PELP1-overexpressing tumors also overexpressed aromatase compared with 36% (n = 47) in PELP1 low-expressing tumors. Our results suggest that PELP1 regulation of aromatase represents a novel mechanism for in situ estrogen synthesis leading to tumor proliferation by autocrine loop and open a new avenue for ablating local aromatase activity in breast tumors.

Original languageEnglish (US)
Pages (from-to)649-664
Number of pages16
JournalMolecular Endocrinology
Volume22
Issue number3
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Autocrine Communication
Aromatase
Estrogen Receptors
Estrogens
Breast Neoplasms
MCF-7 Cells
Neoplasms
human PELP1 protein
Clone Cells
Immunohistochemistry
Phosphatidylinositol 3-Kinase
Carcinoma, Intraductal, Noninfiltrating
Cytoplasmic and Nuclear Receptors
Heterografts
Proline

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1 : Potential estrogen receptor autocrine signaling loop in breast cancer cells. / Rajhans, Rajib; Nair, Hareesh B.; Nair, Sujit S.; Cortez, Valerie; Ikuko, Kijima; Kirma, Nameer B.; Zhou, Dujin; Holden, Alan E.; Brann, Darrell W; Chen, Shiuan; Tekmal, Rajeshwar Rao; Vadlamudi, Ratna K.

In: Molecular Endocrinology, Vol. 22, No. 3, 01.01.2008, p. 649-664.

Research output: Contribution to journalArticle

Rajhans, R, Nair, HB, Nair, SS, Cortez, V, Ikuko, K, Kirma, NB, Zhou, D, Holden, AE, Brann, DW, Chen, S, Tekmal, RR & Vadlamudi, RK 2008, 'Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: Potential estrogen receptor autocrine signaling loop in breast cancer cells', Molecular Endocrinology, vol. 22, no. 3, pp. 649-664. https://doi.org/10.1210/me.2007-0350
Rajhans, Rajib ; Nair, Hareesh B. ; Nair, Sujit S. ; Cortez, Valerie ; Ikuko, Kijima ; Kirma, Nameer B. ; Zhou, Dujin ; Holden, Alan E. ; Brann, Darrell W ; Chen, Shiuan ; Tekmal, Rajeshwar Rao ; Vadlamudi, Ratna K. / Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1 : Potential estrogen receptor autocrine signaling loop in breast cancer cells. In: Molecular Endocrinology. 2008 ; Vol. 22, No. 3. pp. 649-664.
@article{a6570677f1d244bbac48494a2becc117,
title = "Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: Potential estrogen receptor autocrine signaling loop in breast cancer cells",
abstract = "In situ estrogen synthesis is implicated in tumor cell proliferation through autocrine or paracrine mechanisms especially in postmenopausal women. Several recent studies demonstrated activity of aromatase, an enzyme that plays a critical role in estrogen synthesis in breast tumors. Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1/MNAR) is an estrogen receptor (ER) coregulator, and its expression is deregulated in breast tumors. In this study, we examined whether PELP1 promotes tumor growth by promoting local estrogen synthesis using breast cancer cells (MCF7) that stably overexpress PELP1. Immunohistochemistry revealed increased aromatase expression in MCF7-PELP1-induced xenograft tumors. Real-time PCR analysis showed enhanced activation of the aromatase promoter in MCF7-PELP1 clones compared with MCF7 cells. Using a tritiated-water release assay, we demonstrated that MCF7-PELP1 clones exhibit increased aromatase activity compared with control MCF-7 cells. PELP1 deregulation uniquely up-regulated aromatase expression via activation of aromatase promoter I.3/II, and growth factor signaling enhanced PELP1 activation of aromatase. PELP1-mediated induction of aromatase requires functional Src and phosphatidylinositol-3-kinase pathways. Mechanistic studies revealed that PELP1 interactions with ER-related receptor-α and proline-rich nuclear receptor coregulatory protein 2 lead to activation of aromatase. Immunohistochemistry analysis of breast tumor array showed increased expression of aromatase in ductal carcinoma in situ and node-positive tumors compared with no or weak expression in normal breast tissue. Fifty-four percent (n = 79) of PELP1-overexpressing tumors also overexpressed aromatase compared with 36{\%} (n = 47) in PELP1 low-expressing tumors. Our results suggest that PELP1 regulation of aromatase represents a novel mechanism for in situ estrogen synthesis leading to tumor proliferation by autocrine loop and open a new avenue for ablating local aromatase activity in breast tumors.",
author = "Rajib Rajhans and Nair, {Hareesh B.} and Nair, {Sujit S.} and Valerie Cortez and Kijima Ikuko and Kirma, {Nameer B.} and Dujin Zhou and Holden, {Alan E.} and Brann, {Darrell W} and Shiuan Chen and Tekmal, {Rajeshwar Rao} and Vadlamudi, {Ratna K.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1210/me.2007-0350",
language = "English (US)",
volume = "22",
pages = "649--664",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1

T2 - Potential estrogen receptor autocrine signaling loop in breast cancer cells

AU - Rajhans, Rajib

AU - Nair, Hareesh B.

AU - Nair, Sujit S.

AU - Cortez, Valerie

AU - Ikuko, Kijima

AU - Kirma, Nameer B.

AU - Zhou, Dujin

AU - Holden, Alan E.

AU - Brann, Darrell W

AU - Chen, Shiuan

AU - Tekmal, Rajeshwar Rao

AU - Vadlamudi, Ratna K.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - In situ estrogen synthesis is implicated in tumor cell proliferation through autocrine or paracrine mechanisms especially in postmenopausal women. Several recent studies demonstrated activity of aromatase, an enzyme that plays a critical role in estrogen synthesis in breast tumors. Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1/MNAR) is an estrogen receptor (ER) coregulator, and its expression is deregulated in breast tumors. In this study, we examined whether PELP1 promotes tumor growth by promoting local estrogen synthesis using breast cancer cells (MCF7) that stably overexpress PELP1. Immunohistochemistry revealed increased aromatase expression in MCF7-PELP1-induced xenograft tumors. Real-time PCR analysis showed enhanced activation of the aromatase promoter in MCF7-PELP1 clones compared with MCF7 cells. Using a tritiated-water release assay, we demonstrated that MCF7-PELP1 clones exhibit increased aromatase activity compared with control MCF-7 cells. PELP1 deregulation uniquely up-regulated aromatase expression via activation of aromatase promoter I.3/II, and growth factor signaling enhanced PELP1 activation of aromatase. PELP1-mediated induction of aromatase requires functional Src and phosphatidylinositol-3-kinase pathways. Mechanistic studies revealed that PELP1 interactions with ER-related receptor-α and proline-rich nuclear receptor coregulatory protein 2 lead to activation of aromatase. Immunohistochemistry analysis of breast tumor array showed increased expression of aromatase in ductal carcinoma in situ and node-positive tumors compared with no or weak expression in normal breast tissue. Fifty-four percent (n = 79) of PELP1-overexpressing tumors also overexpressed aromatase compared with 36% (n = 47) in PELP1 low-expressing tumors. Our results suggest that PELP1 regulation of aromatase represents a novel mechanism for in situ estrogen synthesis leading to tumor proliferation by autocrine loop and open a new avenue for ablating local aromatase activity in breast tumors.

AB - In situ estrogen synthesis is implicated in tumor cell proliferation through autocrine or paracrine mechanisms especially in postmenopausal women. Several recent studies demonstrated activity of aromatase, an enzyme that plays a critical role in estrogen synthesis in breast tumors. Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1/MNAR) is an estrogen receptor (ER) coregulator, and its expression is deregulated in breast tumors. In this study, we examined whether PELP1 promotes tumor growth by promoting local estrogen synthesis using breast cancer cells (MCF7) that stably overexpress PELP1. Immunohistochemistry revealed increased aromatase expression in MCF7-PELP1-induced xenograft tumors. Real-time PCR analysis showed enhanced activation of the aromatase promoter in MCF7-PELP1 clones compared with MCF7 cells. Using a tritiated-water release assay, we demonstrated that MCF7-PELP1 clones exhibit increased aromatase activity compared with control MCF-7 cells. PELP1 deregulation uniquely up-regulated aromatase expression via activation of aromatase promoter I.3/II, and growth factor signaling enhanced PELP1 activation of aromatase. PELP1-mediated induction of aromatase requires functional Src and phosphatidylinositol-3-kinase pathways. Mechanistic studies revealed that PELP1 interactions with ER-related receptor-α and proline-rich nuclear receptor coregulatory protein 2 lead to activation of aromatase. Immunohistochemistry analysis of breast tumor array showed increased expression of aromatase in ductal carcinoma in situ and node-positive tumors compared with no or weak expression in normal breast tissue. Fifty-four percent (n = 79) of PELP1-overexpressing tumors also overexpressed aromatase compared with 36% (n = 47) in PELP1 low-expressing tumors. Our results suggest that PELP1 regulation of aromatase represents a novel mechanism for in situ estrogen synthesis leading to tumor proliferation by autocrine loop and open a new avenue for ablating local aromatase activity in breast tumors.

UR - http://www.scopus.com/inward/record.url?scp=40849094564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849094564&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0350

DO - 10.1210/me.2007-0350

M3 - Article

VL - 22

SP - 649

EP - 664

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 3

ER -